Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Medi-Weightloss vs MultiMedRx

Medi-Weightloss
Graded #118

Higher grade

vs+11.999999999999993
MultiMedRx
Graded #393

Lower grade

The verdict

Medi-Weightloss takes it — 69.6/100 to 57.6/100.

Medi-Weightloss grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Medi-Weightloss is an established physician-supervised weight-loss brand with 130-plus locations nationwide plus telehealth.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMedi-Weightloss +9
54
45
Dose & formulationMedi-Weightloss +12
65
53
Clinical oversightMedi-Weightloss +8
87
79
Labs & monitoringMedi-Weightloss +37
90
53
FulfillmentMultiMedRx +2
65
67
Contract termsMedi-Weightloss +6
55
49
Medi-Weightloss · left barMultiMedRx · right bar

The numbers

MetricMedi-WeightlossMultiMedRx
WeighScore69.6/10057.6/100
GradeCC
Scorecard rank#118#393
Semaglutide$199/mo (promotional rate, brand-name)Not disclosed
TirzepatideNot disclosedNot disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessYesYes
Oral / sublingualInjection onlyInjection only
Medi-Weightloss

Graded #118 · C

Strengths

  • Both branded (Wegovy, Zepbound) and compounded semaglutide/tirzepatide
  • Established brand with 130+ physician-supervised locations nationwide
  • Telehealth plus in-person clinic options
  • Accepts insurance at many locations; HSA/FSA welcome
  • Includes body-composition analysis and personalized plans

Where it loses points

  • Ongoing medication pricing not transparently posted; varies by plan
  • $199 new-patient visit fee before medication costs
  • Frequent (often weekly) visits expected for some patients
  • Compounded products are not FDA-approved or evaluated
MultiMedRx

Graded #393 · C

Strengths

  • Legal entity disclosed (MMRX MultiMedRx LLC) — uncommon transparency
  • Two physical addresses listed: Newport Beach, CA and Reno, NV
  • LegitScript seal present
  • Features brand-name GLP-1s (Ozempic, Wegovy, Zepbound) — rare in a mostly compounded-only field
  • Broader cardiometabolic menu (metformin, testosterone, HRT) alongside GLP-1

Where it loses points

  • No Mounjaro or Foundayo in the brand-name lineup (only Ozempic, Wegovy, Zepbound)
  • Monthly GLP-1 pricing isn't published — gated behind the consultation
  • $100 consultation fee adds friction; many peers bundle it into the medication price
  • Per-state availability not listed; only CA and NV offices disclosed
  • Whether compounded GLP-1 is offered isn't clear — verify during intake

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard